All Medicines appraisal cards articles
View all stories of the same content type.
-
Medicines appraisal cardsNICE Technology Appraisal 719: Secukinumab for treating non-radiographic axial spondyloarthritis
The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd.
View Cosentyx (secukinumab) prescribing and adverse event reporting information
MLR ID 147195 August 2021 -
Medicines appraisal cards
NICE Technology Appraisal 694: Bempedoic acid▼ with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
The production of this Guidelines card has been commissioned and funded by Daiichi Sankyo UK.
View Bempedoic acid (Nilemdo®▼) & Bempedoic acid and ezetimibe (Nustendi®▼) prescribing and adverse event reporting information
BEM/21/0374 May 2021 -
Medicines appraisal cards
Romosozumab▼ (Evenity®) 105mg solution for injection in prefilled pen SMC2280
The production of this Guidelines card has been commissioned by UCB Pharma Ltd.
Amgen and UCB Pharma Ltd are co-developing Evenity®.
View prescribing information and adverse event reporting
UK-P-RM-OP-2000095 December 2020
